Nationwide surveillance of antimicrobial resistance among non-fermentative Gram-negative bacteria in Intensive Care Units in Taiwan: SMART programme data 2005

International Journal of Antimicrobial Agents

Volumn 33, Issue 3, 2009, Pages 266-271

  Jean, Shio Shin ^a   Hsueh, Po Ren ^b   Lee, Wen Sen ^c   Chang, Hou Tai ^d   Chou, Ming Yuan ^e   Chen, Ing Shen ^f   Wang, Jen Hsien ^g   Lin, Chen Fu ^h   Shyr, Jainn Ming ^h   Ko, Wen Chien ⁱ   Wu, Jiunn Jong ^j   Liu, Yung Ching ^k   Huang, Wen Kuei ^k   Teng, Lee Jene ^b   Liu, Cheng Yi ^l  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^f CARDINAL TIEN HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^j NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^k KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^l TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

more..

Author keywords

Colistin; Extensively drug resistant; Non fermentative Gram negative bacteria; Surveillance; Susceptibility; Tigecycline

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; ISEPAMICIN; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN; TAZOBACTAM; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; GRAM NEGATIVE BACTERIUM; HEALTH PROGRAM; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LENGTH OF STAY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TAIWAN; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; GRAM-NEGATIVE AEROBIC BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MICROBIAL SENSITIVITY TESTS; TAIWAN;

EID: 60249097030     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.08.026     Document Type: Article

References (15)

1. Sader H.S., and Jones R.N. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 25 (2005) 95-109
2. Hsueh P.R., Liu Y.C., Yang D., Yan J.J., Wu T.L., Huang W.K., et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 7 (2001) 373-382
3. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Approved standard M7-A6. Wayne, PA: CLSI; 2005.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. M100-S17. Wayne, PA: CLSI; 2005.
5. Corbella X., Montero A., Pujol M., Domínguez M.A., Ayats J., Argerich M.J., et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38 (2000) 4086-4095
6. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
7. Ishii Y., Alba J., Kimura S., and Yamaguchi K. Evaluation of antimicrobial activity of β-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004). Diagn Microbiol Infect Dis 55 (2006) 143-148
8. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 34 (2002) 634-640
9. Fass R.J., Gregory W.W., D'Amato R.F., Matsen J.M., Wright D.N., and Young L.S. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters. Antimicrob Agents Chemother 34 (1990) 2256-2259
10. Villegas M.V., and Hartstein A.I. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 24 (2003) 284-295
11. Jones R.N., Sader H.S., and Beach M.L. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains of non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 22 (2003) 551-556
12. Seifert H., Stefanik D., and Wisplinghoff H. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates. J Antimicrob Chemother 58 (2006) 1099-1100
13. Traczewski M.M., and Brown S.D. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients. Antimicrob Agents Chemother 50 (2006) 819-821
14. Karlowsky J.A., Draghi D.C., Jones M.E., Thornsberry C., Friedland I.R., and Sahm D.F. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 47 (2003) 1681-1688
15. Neuhauser M.M., Weinstein R.A., Rydman R., Danziger L.H., Karam G., and Quinn J.P. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289 (2003) 885-888